Stocks Health care GCTK

NASDAQ · Health care

Glucotrack, Inc. (GCTK)

It posted a net loss of $15.9M. In fiscal 2025 capital spending exceeded operating cash flow by $15.3M. At June 30, 2026 it held $1.1M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 14, 2026.

What Glucotrack, Inc. does

Glucotrack, Inc. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker GCTK.

Revenue and profit by year

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Full financial statements: income, balance sheet and cash flow

Latest SEC filings

What Glucotrack, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

1. September 24, 2026
   Securities offering prospectus 424B5
2. September 24, 2026
   Material agreement 8-K
3. September 23, 2026
   Form 425 filing 425
4. September 23, 2026
   Investor disclosure 8-K
5. September 18, 2026
   Executive or director change 8-K
6. September 18, 2026
   IPO registration S-1
7. September 14, 2026
   Material agreement 8-K
8. September 11, 2026
   Material agreement 8-K
9. September 9, 2026
   Material agreement 8-K
10. September 2, 2026
    Passive stake (5% or more) SCHEDULE 13G

Recent insider filings (Forms 3, 4 and 144): 10, the latest on October 7, 2025. Insider transactions on SEC

Who owns GCTK

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

Latest filings below 5%: Armistice Capital, LLC 4.99% (May 15, 2026).

Largest institutional holders

No Form 13F positions imported for this company yet.

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

We have not read this company's Form 4 filings yet.

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about GCTK

What does Glucotrack, Inc. do?

Glucotrack, Inc. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker GCTK.

Is Glucotrack, Inc. profitable?

No. Over the twelve months to June 30, 2026 it reported a net loss of $15.9M.

When did Glucotrack, Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 14, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the securities offering prospectus from September 24, 2026.

Similar companies

Compare GCTK with

Compare GCTK with any company

Follow GCTK

Get an email when Glucotrack, Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow GCTK: get an email when it files

Where the numbers come from

Financial figures are the values Glucotrack, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.